Daniel Zimmerman

Track

Insider profile

Currently holds a position at CEL-SCI Corp

Performance

Overall performance
1.6
Performance over holding periods
4.2
30 days 90 days 120 days
Average return 4% 8.2% 15.1%
Success rate 89% 68% 82%
Transactions
3 67% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Performance for realised trades
4.4
Average return -98%
Success rate 73%
Average holding period 220
Transactions 28
Ranking by realised performance

Positions

Position Company Period
Senior Vice President - Research, Cellular Immunology CEL-SCI Corp Nov. 1, 2009 -
Daniel Zimmerman's trades of CEL-SCI Corp's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
US CEL-SCI Corp (CVM)
Transaction date
Purchase
Price
216.12
Quantity 64,916 -15.4%
Value US$2,460,070
US CEL-SCI Corp (CVM)
Transaction date
Sale
Price
298.00
Quantity 66,790 -19.7%
Value US$3,851,884
US CEL-SCI Corp (CVM)
Transaction date
Purchase
Price
129.53
Quantity 12,179 -18.6%
Value US$213,864
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2020-02-27 2020-02-26
US CEL-SCI Corp (CVM)
B Purchase
64,916 -15.4%
216.12
US$2,460,070 		64,916 -15.4% 216.12 US$2,460,070
2019-01-02 2018-12-31
US CEL-SCI Corp (CVM)
S Sale
66,790 -19.7%
298.00
US$3,851,884 		66,790 -19.7% 298.00 US$3,851,884
2004-07-02 2004-06-30
US CEL-SCI Corp (CVM)
B Purchase
12,179 -18.6%
129.53
US$213,864 		12,179 -18.6% 129.53 US$213,864